Heart Test Laboratories
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Heart Test Laboratories generated cash of -$6,070,185, which is less than the previous year. Cash used in financing activities reached the amount of $10,342,637 last year. Net change in cash is therefore $4,147,181.

Cash Flow

Heart Test Laboratories, Inc. (NASDAQ:HSCS): Cash Flow
2020 -3.83M 8.16K 1.81M
2021 -2.45M -712 2.67M
2022 -3.64M -1.93K 3.84M
2023 -5.77M -18.30K 6.53M
2024 -6.07M -125.27K 10.34M

HSCS Cash Flow Statement (2020 – 2024)

2024 2023 2022 2021 2020
Cash at beginning of period
1.66M918.26K723.48K496.85K2.51M
Operating activities
Net income
-6.60M-6.35M-4.82M-2.45M-3.81M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
95.13K26.91K26.56K33.61K63.82K
Stock-based compensation expense
405.02K248.30K68.39K24.67K135.06K
Deferred income tax benefit 405.02K248.30K68.39K24.67K135.06K
Changes in operating assets and liabilities:
Accounts receivable, net
02.32K-2.32K0-7K
Inventories
47.18K-2.22K76.63K106.23K147.31K
Accounts payable
-183.18K37.82K358.96K-20.65K-305.93K
Cash generated by operating activities
-6.07M-5.77M-3.64M-2.45M-3.83M
Investing activities
Purchases Of Investments
00000
Investments In Property Plant And Equipment
-64.45K-18.30K-1.93K-712-11.42K
Acquisitions Net
000019.59K
Cash generated by investing activities
-125.27K-18.30K-1.93K-7128.16K
Financing activities
Common Stock Issued
10.30M5.62M555.76M200K585
Payments for dividends
00000
Repurchases of common stock
00000
Repayments of term debt
42.62K-398.26K4.22M-2.47M-16.97K
Cash used in financing activities
10.34M6.53M3.84M2.67M1.81M
Net Change In Cash
4.14M742.20K194.77K226.62K-2.02M
Cash at end of period
5.80M1.66M918.26K723.48K496.85K
Data sourceData sourceData source